Akciğer Apsesi ve Ampiyem
Synopsis
Empyema is an inflammation of the pleural cavity developing secondary to pneumonia, trauma, or thoracic surgery, and is associated with risk factors such as aspiration, alcohol use, IV drug abuse, poor oral hygiene, immunosuppression, and inadequate pneumonia treatment. In its pathophysiology, which progresses through three stages, the most common pathogen in community-acquired cases is Streptococcus pneumoniae, whereas Staphylococcus aureus predominates in hospital-acquired cases. Clinical presentation resembles pneumonia with persistent fever, tachypnea, and decreased breath sounds; diagnosis utilizes chest X-ray, ultrasonography, computed tomography, and diagnostic/therapeutic thoracentesis. Treatment management is determined according to risk groups; broad-spectrum antibiotics are sufficient in early stages, whereas tube thoracostomy drainage is required in advanced stages. Lung abscess is the destruction of lung parenchyma due to infection, leading to central necrosis and cavitation. Aspiration developing due to old age, alcohol use, dementia, or impaired consciousness is the most common cause, with abscesses mostly localized in the right lung due to anaerobic bacteria. It is classified as acute if symptoms last less than six weeks, and chronic if longer. Physical examination may reveal egophony and increased vocal fremitus; diagnosis is established via chest radiography, CT, and bronchoscopy in non-responsive cases. Treatment involves appropriate broad-spectrum antibiotics for at least four weeks; surgical intervention may be performed in cases unresponsive to six weeks of medical therapy.
References
Petrov DB, Subotic D, Yankov GS, Valev DG, Mekov EV. Epidemiology, Etiology and Prevention of Postpneumonectomy Pleural Empyema. Folia Med (Plovdiv). 2019;61(3):352-357. doi:10.3897/folmed.61.e39120
Shebl E, Paul M. Parapneumonic Pleural Effusions And Empyema Thoracis. In: StatPearls. StatPearls Publishing; 2020. Accessed January 19, 2021. http://www.ncbi.nlm.nih.gov/books/NBK534297/
Krasnik M, Storm HK, Frimodt-Møller N. [Pleural empyema]. Ugeskr Laeger. 1996;158(15):2109-2112.
Aboudara M, Maldonado F. Update in the Management of Pleural Effusions. Med Clin North Am. 2019;103(3):475-485. doi:10.1016/j.mcna.2018.12.007
Kuhajda I, Zarogoulidis K, Tsirgogianni K, et al. Lung abscess-etiology, diagnostic and treatment options. Ann Transl Med. 2015;3(13):183. doi:10.3978/j.issn.2305-5839.2015.07.08
Garvia V, Paul M. Empyema. In: StatPearls. StatPearls Publishing; 2020. Accessed January 19, 2021. http://www.ncbi.nlm.nih.gov/books/NBK459237/
Redden MD, Chin TY, van Driel ML. Surgical versus non‐surgical management for pleural empyema. Cochrane Database Syst Rev. 2017;2017(3). doi:10.1002/14651858.CD010651.pub2
Davis B, Systrom DM. Lung abscess: pathogenesis, diagnosis and treatment. Curr Clin Top Infect Dis. 1998;18:252-273.
Feki W, Ketata W, Bahloul N, Ayadi H, Yangui I, Kammoun S. Abcès du poumon : diagnostic et prise en charge [Lung abscess: Diagnosis and management]. Rev Mal Respir. 2019;36(6):707-719. doi:10.1016/j.rmr.2018.07.010
Wiedemann HP, Rice TW. Lung abscess and empyema [published correction appears in Semin thorac Cardiovasc Surg 1995 Oct;7(4):247]. Semin Thorac Cardiovasc Surg. 1995;7(2):119-128.
Davis B, Systrom DM. Lung abscess: pathogenesis, diagnosis and treatment. Curr Clin Top Infect Dis. 1998;18:252-273.
Soares D, Reis-Melo A, Ferraz C, Guedes Vaz L. Nocardia lung abscess in an immunocompetent adolescent. BMJ Case Rep. 2019;12(1):bcr-2018-227499. Published 2019 Jan 10. doi:10.1136/bcr-2018-227499
Allewelt M, Schüler P, Bölcskei PL, Mauch H, Lode H; Study Group on Aspiration Pneumonia. Ampicillin + sulbactam vs clindamycin +/- cephalosporin for the treatment of aspiration pneumonia and primary lung abscess. Clin Microbiol Infect. 2004;10(2):163-170. doi:10.1111/j.1469-0691.2004.00774.x
Ott SR, Allewelt M, Lorenz J, Reimnitz P, Lode H; German Lung Abscess Study Group. Moxifloxacin vs ampicillin/sulbactam in aspiration pneumonia and primary lung abscess. Infection. 2008;36(1):23-30. doi:10.1007/s15010-007-7043-6